484 related articles for article (PubMed ID: 15998730)
1. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus.
Bonaparte MI; Dimitrov AS; Bossart KN; Crameri G; Mungall BA; Bishop KA; Choudhry V; Dimitrov DS; Wang LF; Eaton BT; Broder CC
Proc Natl Acad Sci U S A; 2005 Jul; 102(30):10652-7. PubMed ID: 15998730
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3.
Sawatsky B; Grolla A; Kuzenko N; Weingartl H; Czub M
J Gen Virol; 2007 Feb; 88(Pt 2):582-591. PubMed ID: 17251577
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
[TBL] [Abstract][Full Text] [Related]
4. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage.
Negrete OA; Chu D; Aguilar HC; Lee B
J Virol; 2007 Oct; 81(19):10804-14. PubMed ID: 17652392
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided mutagenesis of Henipavirus receptor-binding proteins reveals molecular determinants of receptor usage and antibody-binding epitopes.
Oguntuyo KY; Haas GD; Azarm KD; Stevens CS; Brambilla L; Kowdle SS; Avanzato VA; Pryce R; Freiberg AN; Bowden TA; Lee B
J Virol; 2024 Mar; 98(3):e0183823. PubMed ID: 38426726
[TBL] [Abstract][Full Text] [Related]
6. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
[TBL] [Abstract][Full Text] [Related]
7. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins.
Bossart KN; Wang LF; Flora MN; Chua KB; Lam SK; Eaton BT; Broder CC
J Virol; 2002 Nov; 76(22):11186-98. PubMed ID: 12388678
[TBL] [Abstract][Full Text] [Related]
8. Novel Functions of Hendra Virus G N-Glycans and Comparisons to Nipah Virus.
Bradel-Tretheway BG; Liu Q; Stone JA; McInally S; Aguilar HC
J Virol; 2015 Jul; 89(14):7235-47. PubMed ID: 25948743
[TBL] [Abstract][Full Text] [Related]
9. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
[TBL] [Abstract][Full Text] [Related]
10. Mutations in the G-H loop region of ephrin-B2 can enhance Nipah virus binding and infection.
Yuan J; Marsh G; Khetawat D; Broder CC; Wang LF; Shi Z
J Gen Virol; 2011 Sep; 92(Pt 9):2142-2152. PubMed ID: 21632558
[TBL] [Abstract][Full Text] [Related]
11. Detection of Nipah and Hendra Viruses Using Recombinant Human Ephrin B2 Capture Virus in Immunoassays.
Yang M; Zhu W; Truong T; Pickering B; Babiuk S; Kobasa D; Banadyga L
Viruses; 2022 Jul; 14(8):. PubMed ID: 36016279
[TBL] [Abstract][Full Text] [Related]
12. Nipah and Hendra Virus Glycoproteins Induce Comparable Homologous but Distinct Heterologous Fusion Phenotypes.
Bradel-Tretheway BG; Zamora JLR; Stone JA; Liu Q; Li J; Aguilar HC
J Virol; 2019 Jul; 93(13):. PubMed ID: 30971473
[TBL] [Abstract][Full Text] [Related]
13. Glycoprotein attachment with host cell surface receptor ephrin B2 and B3 in mediating entry of nipah and hendra virus: a computational investigation.
Priyadarsinee L; Sarma H; Sastry GN
J Chem Sci (Bangalore); 2022; 134(4):114. PubMed ID: 36465097
[TBL] [Abstract][Full Text] [Related]
14. Headless Henipaviral Receptor Binding Glycoproteins Reveal Fusion Modulation by the Head/Stalk Interface and Post-receptor Binding Contributions of the Head Domain.
Yeo YY; Buchholz DW; Gamble A; Jager M; Aguilar HC
J Virol; 2021 Sep; 95(20):e0066621. PubMed ID: 34288734
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2.
Bowden TA; Aricescu AR; Gilbert RJ; Grimes JM; Jones EY; Stuart DI
Nat Struct Mol Biol; 2008 Jun; 15(6):567-72. PubMed ID: 18488039
[TBL] [Abstract][Full Text] [Related]
16. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
[TBL] [Abstract][Full Text] [Related]
17. Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.
Narayanan KK; Amaya M; Tsang N; Yin R; Jays A; Broder CC; Shukla D; Procko E
J Virol; 2023 Nov; 97(11):e0062123. PubMed ID: 37931130
[TBL] [Abstract][Full Text] [Related]
18. Efficient reverse genetics reveals genetic determinants of budding and fusogenic differences between Nipah and Hendra viruses and enables real-time monitoring of viral spread in small animal models of henipavirus infection.
Yun T; Park A; Hill TE; Pernet O; Beaty SM; Juelich TL; Smith JK; Zhang L; Wang YE; Vigant F; Gao J; Wu P; Lee B; Freiberg AN
J Virol; 2015 Jan; 89(2):1242-53. PubMed ID: 25392218
[TBL] [Abstract][Full Text] [Related]
19. Expression, characterisation and antigenicity of a truncated Hendra virus attachment protein expressed in the protozoan host Leishmania tarentolae.
Fischer K; dos Reis VP; Finke S; Sauerhering L; Stroh E; Karger A; Maisner A; Groschup MH; Diederich S; Balkema-Buschmann A
J Virol Methods; 2016 Feb; 228():48-54. PubMed ID: 26585033
[TBL] [Abstract][Full Text] [Related]
20. Prefusion stabilization of the Hendra and Langya virus F proteins.
Byrne PO; Blade EG; Fisher BE; Ambrozak DR; Ramamohan AR; Graham BS; Loomis RJ; McLellan JS
J Virol; 2024 Feb; 98(2):e0137223. PubMed ID: 38214525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
